It was developed by Donato Perez Garcia, MD in 1930 as a targeted therapy for chronic degenerative diseases and some types of cancer.
It was developed by Donato Perez Garcia as a targeted therapy for chronic degenerative diseases. It was developed by Donato Perez Garcia as some types of cancer. Donato Perez Garcia was MD in 1930.